I M M U N E T O L E R A N C E I N D U C T I O N S T U D Y
Welcome to the International Immune Tolerance Study Home Page.
The Study opened for recruitment late in 2002, after a delay due to the shortage of recombinant factor VIII.
The study compares the efficacy, morbidity and cost effectiveness of low versus high-dose
immune tolerance in good-risk patients.
These patients have severe haemophilia A, an inhibitor for 12 months or less and a historical peak inhibitor titre of >
5BU but < 200 units.
The electronic case report form (eCRF) used in the study requires Internet Explorer V4.1 or later.
Protocol Introduction
Study Objectives and Hypothesis
Contact Information
Posters, latest newsletter and minutes from last meeting
How to join the study
122 Patients recruited into the study
The next Investigator meeting will be held during the ISTH conference in Boston
Date and time to be confirmed
Enter Electronic C.R.F.
Please read the security information for Internet Explorer V5.0 or later
Please read the security information for Internet Explorer V5.0 or later
Web pages developed by: Dr R.A.Hollingsworth